Journal of Vascular and Interventional Radiology最新文献

英文中文

Balloon-Guided Aspiration Thrombectomy of Internal Carotid Artery following Penetrating and Blunt Injury through the Skull Base 颅底穿透性钝性损伤后的颈内动脉球囊引导抽吸取栓术

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.09.035

Sonam Santdasani APRN, FNP-BC , Jesse Liu MD , Scott Rewinkel MD , Marco Colasurdo MD

引用次数: 0

Atherectomy versus Stent Placement for Common Femoral Artery Atherosclerotic Disease: A Systematic Review 动脉粥样硬化切除术与支架置入术治疗普通股动脉粥样硬化疾病：一项系统综述。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.08.015

Mathias Montveneur MD , Guillaume Daniel MD , Pierre-Jules Delannoy MD , Kinga Michalewska MD , Sonia Ramos-Pascual MEng, PhD , Mo Saffarini MEng, MBA , Nicolas Bouchareine MD

Purpose

To compare the outcomes of atherectomy versus stent placement for common femoral artery (CFA) symptomatic atherosclerosis.

Materials and Methods

This review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered in PROSPERO. MEDLINE and Embase databases were searched for records from 2000 to 2023. The following data were extracted and tabulated: (a) characteristics of studies, (b) patients, (c) lesions and interventions, and (d) clinical and technical outcomes. Risk of bias was assessed using Mixed Methods Appraisal Tool (MMAT).

Results

The search identified 2,088 references, of which 33 studies were included: 11 reported only on atherectomy, 20 reported only on stent placement, and 2 reported on both treatments. Atherectomy and stent placement studies were comparable in terms of age, sex, prevalence of comorbidities, chronic limb ischemia, preprocedural Rutherford score, and ankle-brachial index. Technical success ranged across the studies from 92% to 100% for atherectomy versus 94% to 100% for stent placement, periprocedural adverse event rates ranged from 0% to 24% versus 0% to 19%, rates of freedom from target lesion revascularization ranged from 83% to 100% versus 81% to 100%, and limb salvage rates ranged from 85% to 100% versus 94% to 100%. Stent fracture rates ranged from 0% to 8%. Only 5 of 13 studies on atherectomy and 5 of 22 studies on stent placement met all 7 MMAT criteria.

Conclusions

This systematic review demonstrates satisfactory outcomes with both methods, with no clear advantage of one technique over the other. However, available data on these 2 techniques are heterogeneous. Future studies are necessary to conclude if either technique is superior for the treatment of symptomatic CFA atherosclerosis.

目的：比较动脉粥样硬化切除术与支架置入术治疗股总动脉（CFA）症状性动脉粥样硬化的效果。方法：本综述遵循PRISMA指南，并在PROSPERO注册。检索MEDLINE和Embase数据库2000 - 2023年的记录。提取并制表以下数据：研究特征、患者、病变和干预措施，以及临床和技术结果。使用混合方法评估工具（MMAT）评估偏倚风险。结果：检索到2088篇文献，其中包括33篇研究：11篇仅报道动脉粥样硬化切除术，20篇仅报道支架置入术，2篇两种治疗均报道。动脉粥样硬化切除术和支架置入研究在年龄、性别、合并症患病率、慢性肢体缺血、术前卢瑟福和ABI方面似乎具有可比性。所有研究的技术成功率从动脉粥样硬化切除术的92% -100%到支架置入的94% -100%不等，围手术期并发症从0-24%到0-19%不等，TLR的自由度从83-100%到81-100%不等，肢体保留从85-100%到94-100%不等。支架骨折率从0-8%不等。13项动脉粥样硬化切除术研究中只有5项，22项支架植入研究中只有5项符合MMAT的全部7项标准。结论：动脉粥样硬化切除术和支架植入术似乎为有症状的CFA动脉粥样硬化提供了可比较且有利的结果。然而，没有前瞻性研究直接比较这两种技术，可用的数据是异构的。未来的研究需要得出结论，这两种技术中是否有一种更适合治疗有症状的CFA动脉粥样硬化。

{"title":"Atherectomy versus Stent Placement for Common Femoral Artery Atherosclerotic Disease: A Systematic Review","authors":"Mathias Montveneur MD , Guillaume Daniel MD , Pierre-Jules Delannoy MD , Kinga Michalewska MD , Sonia Ramos-Pascual MEng, PhD , Mo Saffarini MEng, MBA , Nicolas Bouchareine MD","doi":"10.1016/j.jvir.2025.08.015","DOIUrl":"10.1016/j.jvir.2025.08.015","url":null,"abstract":"<div><h3>Purpose</h3><div>To compare the outcomes of atherectomy versus stent placement for common femoral artery (CFA) symptomatic atherosclerosis.</div></div><div><h3>Materials and Methods</h3><div>This review followed Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and was registered in PROSPERO. MEDLINE and Embase databases were searched for records from 2000 to 2023. The following data were extracted and tabulated: (<em>a</em>) characteristics of studies, (<em>b</em>) patients, (<em>c</em>) lesions and interventions, and (<em>d</em>) clinical and technical outcomes. Risk of bias was assessed using Mixed Methods Appraisal Tool (MMAT).</div></div><div><h3>Results</h3><div>The search identified 2,088 references, of which 33 studies were included: 11 reported only on atherectomy, 20 reported only on stent placement, and 2 reported on both treatments. Atherectomy and stent placement studies were comparable in terms of age, sex, prevalence of comorbidities, chronic limb ischemia, preprocedural Rutherford score, and ankle-brachial index. Technical success ranged across the studies from 92% to 100% for atherectomy versus 94% to 100% for stent placement, periprocedural adverse event rates ranged from 0% to 24% versus 0% to 19%, rates of freedom from target lesion revascularization ranged from 83% to 100% versus 81% to 100%, and limb salvage rates ranged from 85% to 100% versus 94% to 100%. Stent fracture rates ranged from 0% to 8%. Only 5 of 13 studies on atherectomy and 5 of 22 studies on stent placement met all 7 MMAT criteria.</div></div><div><h3>Conclusions</h3><div>This systematic review demonstrates satisfactory outcomes with both methods, with no clear advantage of one technique over the other. However, available data on these 2 techniques are heterogeneous. Future studies are necessary to conclude if either technique is superior for the treatment of symptomatic CFA atherosclerosis.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107798"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144976705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Outcomes following Mechanical Thrombectomy in Pulmonary Embolism Response Team–Consulted Patients: A Retrospective Analysis 肺栓塞反应小组咨询患者机械取栓后的临床结果：回顾性分析。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.09.008

Ryan Nolan BS , Maanasi Samant MD , Suresh Vedantham MD , Westley Ohman MD , Nathan Droz MD , Kristen Sanfilippo MD, MPHS , Pavan Kavali MD

Purpose

To determine if use of mechanical thrombectomy (MT) impacts survival and additional outcomes in patients with acute intermediate-high–risk and high-risk pulmonary embolism (PE) who were evaluated by a Pulmonary Embolism Response Team (PERT).

Methods

This retrospective, single-center study included patients with intermediate-high–risk and high-risk PE who received PERT evaluation over 3.5 years and were treated with anticoagulation (AC) alone or MT + AC. The primary outcome was 30-day all-cause mortality, measured with inverse probability of treatment weighting. Exploratory outcomes included survival during the study period, PE-associated/caused mortality, hospital length of stay (LOS), supplemental oxygen at discharge, and MT-related metrics.

Results

Of 335 patients, 259 received AC alone and 76 received MT + AC. The use of MT was associated with reduced odds of 30-day all-cause mortality (odds ratio, 0.49; 95% CI, 0.27–0.76; P = .002). There were no significant differences in PE-associated/caused mortality. Hospital LOS was 2 days shorter in the MT + AC cohort (P < .001). Of patients receiving MT + AC, those with high-risk PE had a 4.5-day shorter stay (P < .001), whereas those with intermediate-high–risk PE had a 2-day shorter stay (P < .001). The proportion of patients receiving supplemental oxygen at discharge was lower in the MT + AC group (MT + AC vs AC, 4.1% vs 18.5%; P < .001), without significant differences in 30-day readmission rates (MT + AC vs AC, 9.5% vs 20.6%; P = .115). MT resulted in an 8.7-mm Hg reduction in mean pulmonary artery pressure, had a technical success rate of 100% (76 of 76), and an adverse event rate of 6.6% (5 of 76).

Conclusions

MT reduced 30-day all-cause mortality, hospital LOS, and supplemental oxygen at discharge in the intermediate-high–risk and high-risk PE population.

目的：该研究旨在确定机械取栓（MT）的使用是否会影响急性中、高、高风险肺栓塞（PE）患者的生存和其他结果，PE反应小组（PERT）对这些患者进行了评估。方法：这项回顾性、单中心研究纳入了接受PERT评估超过3.5年的中高、高危PE患者，这些患者接受抗凝治疗（AC）或MT+抗凝治疗（MT+AC）。主要终点是30天全因死亡率，用治疗加权的逆概率测量。探索性结果包括研究期间的生存率、pe相关/引起的死亡率、住院时间（LOS）、出院时补充氧气和mt相关指标。结果：335例患者中，259例单独接受AC治疗，76例接受MT+AC治疗。MT的使用与30天全因死亡率降低相关（OR=0.49, 95%CI=0.27-0.76, p=0.002）。pe相关/引起的死亡率没有显著差异。在MT+AC队列中，医院LOS缩短了2天（p结论：MT降低了30天的全因死亡率、医院LOS和中高风险PE人群出院时的补充氧）。

{"title":"Clinical Outcomes following Mechanical Thrombectomy in Pulmonary Embolism Response Team–Consulted Patients: A Retrospective Analysis","authors":"Ryan Nolan BS , Maanasi Samant MD , Suresh Vedantham MD , Westley Ohman MD , Nathan Droz MD , Kristen Sanfilippo MD, MPHS , Pavan Kavali MD","doi":"10.1016/j.jvir.2025.09.008","DOIUrl":"10.1016/j.jvir.2025.09.008","url":null,"abstract":"<div><h3>Purpose</h3><div>To determine if use of mechanical thrombectomy (MT) impacts survival and additional outcomes in patients with acute intermediate-high–risk and high-risk pulmonary embolism (PE) who were evaluated by a Pulmonary Embolism Response Team (PERT).</div></div><div><h3>Methods</h3><div>This retrospective, single-center study included patients with intermediate-high–risk and high-risk PE who received PERT evaluation over 3.5 years and were treated with anticoagulation (AC) alone or MT + AC. The primary outcome was 30-day all-cause mortality, measured with inverse probability of treatment weighting. Exploratory outcomes included survival during the study period, PE-associated/caused mortality, hospital length of stay (LOS), supplemental oxygen at discharge, and MT-related metrics.</div></div><div><h3>Results</h3><div>Of 335 patients, 259 received AC alone and 76 received MT + AC. The use of MT was associated with reduced odds of 30-day all-cause mortality (odds ratio, 0.49; 95% CI, 0.27–0.76; <em>P</em> = .002). There were no significant differences in PE-associated/caused mortality. Hospital LOS was 2 days shorter in the MT + AC cohort (<em>P</em> < .001). Of patients receiving MT + AC, those with high-risk PE had a 4.5-day shorter stay (<em>P</em> < .001), whereas those with intermediate-high–risk PE had a 2-day shorter stay (<em>P</em> < .001). The proportion of patients receiving supplemental oxygen at discharge was lower in the MT + AC group (MT + AC vs AC, 4.1% vs 18.5%; <em>P</em> < .001), without significant differences in 30-day readmission rates (MT + AC vs AC, 9.5% vs 20.6%; <em>P</em> = .115). MT resulted in an 8.7-mm Hg reduction in mean pulmonary artery pressure, had a technical success rate of 100% (76 of 76), and an adverse event rate of 6.6% (5 of 76).</div></div><div><h3>Conclusions</h3><div>MT reduced 30-day all-cause mortality, hospital LOS, and supplemental oxygen at discharge in the intermediate-high–risk and high-risk PE population.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107836"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Lessons in IR: Management of Radial Artery Pseudoaneurysm with Extended Hemostatic Band Compression IR的经验教训：扩展止血带压迫桡动脉假性动脉瘤的治疗

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.09.016

Aren B. Mnatzakanian MD , Bronwyn L. Schemmer BHSc , Neil J. Resnick MD , Karim Virani MD, MSc

引用次数: 0

Percutaneous Reduction-Fixation of a Displaced Odontoid Fracture Causing Medullary Compression 经皮复位固定移位齿状突骨折导致髓质受压

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.08.029

Nicolas Stacoffe MD, Joris Lavigne MD, Bastien Chalamet MD, Mohamed-Ilyess BenRejeb MD, Jean-Baptiste Pialat MD, PhD

引用次数: 0

Lung Tumors Marked Percutaneously with Indocyanine Green Dye–Soaked Embolization Coils: A Visual Beacon for Accurate Intraoperative Localization during Lung-Sparing Surgery 经皮吲哚菁绿染料浸泡栓塞线圈标记肺肿瘤：肺保留手术术中准确定位的视觉信标。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.08.042

Edward J. Walsh MD , Hasnain Bawaadam MD, MPH , Joseph G. Mammarappallil MD, PhD , Jason R. Snider MD , William C. Allsopp DO , Frederick J. Brodeur MD , Aaron R. Green MD , Ganesh Krishna MD , Brandon M. Wojcik MD

Thoracic surgeons using minimally invasive techniques for lung nodule resection often rely on localization markers to determine precise nodule location intraoperatively. Transbronchial or transthoracic injection of indocyanine green (ICG) dye has become a popular technique. However, surgery must be performed immediately before dye dissipates into surrounding tissue. This multicenter retrospective study evaluated the effectiveness of computed tomography (CT)–guided transthoracic placement of ICG dye–soaked coils (ICG-Cs) for preoperative lung nodule localization. Nineteen adult patients with 21 nodules underwent CT ICG-C placement from March 01, 2023, until February 28, 2025, at 2 medical centers. There were no adverse events. Median time from localization to surgery was 1 day (interquartile range, 0–4 days), with 57.1% undergoing surgery >24 hours later. Localization success rate was 100%. CT-guided transthoracic placement of ICG-C is a novel technique that allows for accurate nodule localization, delayed surgical resection, and the preservation of healthy lung tissue.

胸外科医生采用微创技术进行肺结节切除术，术中往往依靠定位标记来确定精确的结节位置。经支气管或经胸注射吲哚菁绿（ICG）染料已成为一种流行的技术。然而，手术必须立即进行，因为染料会消散到周围组织。本多中心回顾性研究评估了CT引导下经胸放置ICG染料浸透线圈（CT ICG- c）在术前肺结节定位中的效果。2023年3月1日至2025年2月28日，19例21个结节的成年患者在两个医疗中心接受了CT ICG-C定位。没有不良事件发生。从定位到手术的中位时间为1天（IQR 0 ~ 4天），57.1%的患者在24小时后接受手术。本地化成功率100%。CT ICG-C是一种新颖的技术，可以精确定位结节，延迟手术切除，并保留健康的肺组织。

{"title":"Lung Tumors Marked Percutaneously with Indocyanine Green Dye–Soaked Embolization Coils: A Visual Beacon for Accurate Intraoperative Localization during Lung-Sparing Surgery","authors":"Edward J. Walsh MD , Hasnain Bawaadam MD, MPH , Joseph G. Mammarappallil MD, PhD , Jason R. Snider MD , William C. Allsopp DO , Frederick J. Brodeur MD , Aaron R. Green MD , Ganesh Krishna MD , Brandon M. Wojcik MD","doi":"10.1016/j.jvir.2025.08.042","DOIUrl":"10.1016/j.jvir.2025.08.042","url":null,"abstract":"<div><div>Thoracic surgeons using minimally invasive techniques for lung nodule resection often rely on localization markers to determine precise nodule location intraoperatively. Transbronchial or transthoracic injection of indocyanine green (ICG) dye has become a popular technique. However, surgery must be performed immediately before dye dissipates into surrounding tissue. This multicenter retrospective study evaluated the effectiveness of computed tomography (CT)–guided transthoracic placement of ICG dye–soaked coils (ICG-Cs) for preoperative lung nodule localization. Nineteen adult patients with 21 nodules underwent CT ICG-C placement from March 01, 2023, until February 28, 2025, at 2 medical centers. There were no adverse events. Median time from localization to surgery was 1 day (interquartile range, 0–4 days), with 57.1% undergoing surgery >24 hours later. Localization success rate was 100%. CT-guided transthoracic placement of ICG-C is a novel technique that allows for accurate nodule localization, delayed surgical resection, and the preservation of healthy lung tissue.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107825"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145008507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Safety and Effectiveness of Transarterial Chemoembolization for Caudate Lobe Hepatocellular Carcinoma: Long-Term Clinical Outcomes 经动脉化疗栓塞治疗尾状叶肝癌的安全性和有效性：长期临床结果。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.09.038

Eunbyeol Ko BS, Jin Hyoung Kim MD, Jihoon Kim MD, Gun Ha Kim MD, Heung-Kyu Ko MD, Hee Ho Chu MD, Ji Hoon Shin MD, Dong Il Gwon MD, Byung Soo Im MD, Gi-Young Ko MD

Purpose

To evaluate the safety and effectiveness of transarterial chemoembolization (TACE) as first-line treatment for single caudate lobe hepatocellular carcinoma (HCC).

Materials and Methods

A total of 107 treatment-naive patients who received TACE between 2006 and 2023 as first-line treatment for single caudate lobe HCC were retrospectively evaluated. Adverse events, radiologic tumor response, progression-free survival (PFS), and overall survival (OS) following TACE were investigated. Periprocedural variables related to complete response (CR) and OS were investigated using multivariable regression analyses.

Results

Complete TACE (cisplatin, ethiodized oil, and gelatin foam particles) through all tumor-feeding caudate arteries was possible in 73% of the study patients. The severe adverse event rate was 2.8%. A CR at 1 month after TACE was achieved in 67% of the study patients, and multivariable analysis showed that complete TACE (P < .001; odds ratio [OR], 42.86) and a single tumor-feeding artery (P = .002; OR, 8.04) were significant predictors of a CR. The median PFS after TACE was 29 months. After TACE, the 3-, 5-, and 10-year OS rates were 62%, 46%, and 33%, respectively, and the median OS was 53 months. Multivariable analysis revealed 4 significant periprocedural risk factors: (a) incomplete TACE (P = .004; hazard ratio [HR], 2.69), (b) multiple tumor-feeding arteries (P = .04; HR, 2.02), (c) Child-Pugh Class B (P = .003; HR, 2.91), and (d) advanced-stage HCC (P = .02; HR, 3.43).

Conclusions

TACE appears to be a safe and potentially effective first-line treatment option, with long PFS, for patients with single HCC located in the caudate lobe.

目的：评价经动脉化疗栓塞（TACE）作为单发尾状叶肝癌（HCC）一线治疗的安全性和有效性。材料和方法：对2006年至2023年间接受TACE治疗的107例单发尾状叶HCC患者进行回顾性分析。研究了TACE后的不良事件、放射学肿瘤反应、无进展生存期（PFS）和总生存期（OS）。采用多变量回归分析研究与完全缓解（CR）和OS相关的围手术期变量。结果：73%的研究患者可以通过所有肿瘤供血的尾状动脉进行完全TACE（顺铂、乙基化油和明胶泡沫颗粒）。严重不良事件发生率为2.8%。67%的研究患者在TACE治疗后1个月达到CR，多变量分析显示完全TACE治疗(P)结论：对于位于尾状叶的单个HCC患者，TACE似乎是一种安全且潜在有效的一线治疗选择，PFS较长。

{"title":"Safety and Effectiveness of Transarterial Chemoembolization for Caudate Lobe Hepatocellular Carcinoma: Long-Term Clinical Outcomes","authors":"Eunbyeol Ko BS, Jin Hyoung Kim MD, Jihoon Kim MD, Gun Ha Kim MD, Heung-Kyu Ko MD, Hee Ho Chu MD, Ji Hoon Shin MD, Dong Il Gwon MD, Byung Soo Im MD, Gi-Young Ko MD","doi":"10.1016/j.jvir.2025.09.038","DOIUrl":"10.1016/j.jvir.2025.09.038","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the safety and effectiveness of transarterial chemoembolization (TACE) as first-line treatment for single caudate lobe hepatocellular carcinoma (HCC).</div></div><div><h3>Materials and Methods</h3><div>A total of 107 treatment-naive patients who received TACE between 2006 and 2023 as first-line treatment for single caudate lobe HCC were retrospectively evaluated. Adverse events, radiologic tumor response, progression-free survival (PFS), and overall survival (OS) following TACE were investigated. Periprocedural variables related to complete response (CR) and OS were investigated using multivariable regression analyses.</div></div><div><h3>Results</h3><div>Complete TACE (cisplatin, ethiodized oil, and gelatin foam particles) through all tumor-feeding caudate arteries was possible in 73% of the study patients. The severe adverse event rate was 2.8%. A CR at 1 month after TACE was achieved in 67% of the study patients, and multivariable analysis showed that complete TACE (<em>P</em> < .001; odds ratio [OR], 42.86) and a single tumor-feeding artery (<em>P</em> = .002; OR, 8.04) were significant predictors of a CR. The median PFS after TACE was 29 months. After TACE, the 3-, 5-, and 10-year OS rates were 62%, 46%, and 33%, respectively, and the median OS was 53 months. Multivariable analysis revealed 4 significant periprocedural risk factors: (<em>a</em>) incomplete TACE (<em>P</em> = .004; hazard ratio [HR], 2.69), (<em>b</em>) multiple tumor-feeding arteries (<em>P</em> = .04; HR, 2.02), (<em>c</em>) Child-Pugh Class B (<em>P</em> = .003; HR, 2.91), and (<em>d</em>) advanced-stage HCC (<em>P</em> = .02; HR, 3.43).</div></div><div><h3>Conclusions</h3><div>TACE appears to be a safe and potentially effective first-line treatment option, with long PFS, for patients with single HCC located in the caudate lobe.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107867"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Strategies to Optimize Success in Breast Cancer Cryoablation 优化乳腺癌冷冻消融成功率的策略。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.09.039

Nikiforos Vasiniotis Kamarinos MD , Peter J. Littrup MD , Constantinos T. Sofocleous MD, PhD , Stephen B. Solomon MD , Robert C. Ward MD

Breast cryoablation is a minimally invasive procedure that has demonstrated feasibility, tolerability, and effectiveness in eradicating small breast cancers. The integration of multimodal imaging systems is crucial for optimal patient selection, precise tumor targeting, and complete tumor eradication. Expanding the use of cryoablation to larger tumors may be feasible by leveraging established ablation techniques, such as ablation margin confirmation and postablation biopsy.

乳房冷冻消融是一种微创手术，在根除小乳腺癌方面已经证明了可行性、耐受性和有效性。多模态成像系统的整合对于最佳患者选择、精确肿瘤靶向和完全肿瘤根除至关重要。利用现有的消融技术，如消融边缘确认和消融后活检，将冷冻消融的应用范围扩大到更大的肿瘤可能是可行的。

引用次数: 0

Protein-Losing Enterofpathy Treated by Endoscopic Embolization of Lymphatic Leakage in the Duodenum 内镜下十二指肠淋巴渗漏栓塞治疗蛋白质丢失性肠病。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.10.005

Deborah Rabinowitz MD , Gabriele Meyer DO , J. Fernando Del Rosario MD , Maxim Itkin MD

引用次数: 0

Aliya as High-Frequency Irreversible Electroporation: A Call for Consistent Pulsed Electric Field Terminology in IR Literature Aliya作为高频IRE：介入放射学文献中一致的PEF术语的呼吁。

IF 2.6 3区医学 Q2 PERIPHERAL VASCULAR DISEASE

Journal of Vascular and Interventional Radiology

Pub Date : 2026-01-01 DOI: 10.1016/j.jvir.2025.107988

Hamidreza Rouientan MD , Mohammad Ghasemi-Rad MD , Shahram Akhlaghpoor MD

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Journal of Vascular and Interventional Radiology

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀